Number of the records: 1
Sorafenib-irinotecan sequential therapy augmented the anti-tumor efficacy of monotherapy in hepatocellular carcinoma cells HepG2
- Sorafenib-irinotecan sequential therapy augmented the anti-tumor efficacy of monotherapy in hepatocellular carcinoma cells HepG2 / Z. Wang ... [et al.] . Neoplasma : journal of experimental and clinical oncology. - ISSN 0028-2685 . - Vol. 62, no. 2 (2015), s. 172-179 : ilustr., grafy, tab.
- C 720
article
Number of the records: 1